H5N1 influenza is evolving rapidly, weakening the effectiveness of existing antibodies and increasing its potential threat to ...

A vaccine's ability to generate long-lasting, high-affinity antibodies hinges on a delicate balance. Upon exposure to a ...

Mucormycosis or ‘black fungus’, is a fungal infection affecting the sinuses, lungs, brain, and skin. The fungal infection is ...

New computational modeling of avian influenza variants' immunoprotein interactions—developed by a research team at the ...

The H5N1 avian influenza virus is mutating to evade immune defenses in mammals following prior infection or vaccination.

Successful high-affinity B cells can proliferate under special conditions that reduce the risk of mutation. Capturing this ...

New imaging reveals a built-in safeguard that allows B cell populations to rapidly expand in germinal centers without ...

ProMIS Neurosciences (PMN) announced plans to deliver virtual oral presentations at the 2025 Alzheimer’s and Parkison’s Disease International ...

Leveragen Inc., a Boston-based biotechnology company specializing in next-generation genetic models for antibody discovery, ...

Presented preclinical non-human primate (NHP) data at the 20th Congress of European Crohn’s and Colitis Organization in Inflammatory Bowel ...

New computational modeling of avian influenza variants’ immunoprotein interactions – developed by a research team at the University of North Carolina at Charlotte – reveals the H5N1 influenza virus is ...